Unlocking the potential of engineered immune cell therapy for solid tumors

Other authors

Institut Català de la Salut

[Albarrán-Fernández V, Angelats L] Medical Oncology Department, Hospital Clínic, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. [Delgado J, Urbano-Ispizua Á] Oncoimmunotherapy Unit, Department of Hematology, Hospital Clínic, Barcelona, Spain. Department of Medicine, University of Barcelona, Barcelona, Spain. [Gros A] Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gueda S] Cellular Immunotherapies for Cancer, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2025-04-01T08:49:51Z

2025-04-01T08:49:51Z

2025-01-29



Abstract

Immune cell therapy; Solid tumors


Teràpia cel·lular immune, Tumors sòlids


Terapia cel·lular inmune; Tumores sólidos


Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellular products with enhanced cytotoxicity, phenotype, and metabolism.

Document Type

Article


Published version

Language

English

Publisher

Nature Portfolio

Related items

Nature Communications;16

https://doi.org/10.1038/s41467-025-56527-0

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)